Literature DB >> 19172128

British paediatric surveillance unit study of biliary atresia: outcome at 13 years.

P J McKiernan1, Alastair J Baker, Carla Lloyd, Giorgina Mieli-Vergani, Deirdre A Kelly.   

Abstract

BACKGROUND: Little information is available on contemporary, prospectively collected data on the long-term outcome of national cohorts of children with biliary atresia.
OBJECTIVE: This study aimed to describe the current outcome of a national cohort of children with biliary atresia. PATIENTS AND METHODS: All 93 cases of biliary atresia in the United Kingdom and Ireland diagnosed between March 1993 and February 1995 were followed up prospectively.
RESULTS: A total of 91 children underwent Kasai portoenterostomy in 15 individual centres. Only 2 centres treated more than 5 children annually. Median age at last follow-up was 12 years (range 0.25-14). Fifteen children (16%) have died: 10 after unsuccessful portoenterostomy, 1 of sepsis after successful portoenterostomy, and 4 after liver transplantation. Forty-two (45%) underwent liver transplantation at a median age of 1 year (range 0.5-9), with 90% survival. All 41 children with failed portoenterostomy (and 2 without portoenterostomy) died or underwent liver transplantation at a median age of 0.8 years (range 0.25-6.5). When the portoenterostomy was successful, 40 of 50 patients (80%) are alive without liver transplantation. The 13-year actuarial survival without liver transplantation is 43.8% overall and is better in children treated at centres that treat more than 5 cases yearly (54% vs 27.3%, P = 0.005).
CONCLUSIONS: If the portoenterostomy is successful, then few children with biliary atresia will need transplantation before adolescence. Children with biliary atresia should be treated in experienced centres to maximize the chance of successful surgery.

Entities:  

Mesh:

Year:  2009        PMID: 19172128     DOI: 10.1097/MPG.0b013e31817d80de

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  9 in total

1.  Clinical practices among healthcare professionals concerning neonatal jaundice and pale stools.

Authors:  Ermelinda Santos Silva; Helena Moreira Silva; Lia Azevedo Lijnzaat; Cláudia Melo; Elísio Costa; Esmeralda Martins; Ana Isabel Lopes
Journal:  Eur J Pediatr       Date:  2017-01-12       Impact factor: 3.183

Review 2.  Screening for biliary atresia.

Authors:  Akira Matsui
Journal:  Pediatr Surg Int       Date:  2017-10-05       Impact factor: 1.827

3.  Biliary Atresia - Too Few, Too Many Centers.

Authors:  Jorge Amil Dias
Journal:  GE Port J Gastroenterol       Date:  2017-11-16

Review 4.  Clinical practice: management of biliary atresia.

Authors:  Basem A Khalil; M Thamara P R Perera; Darius F Mirza
Journal:  Eur J Pediatr       Date:  2009-12-18       Impact factor: 3.183

5.  Neonatal cholestasis: opportunities to increase early detection.

Authors:  Joseph J Palermo; Shannon Joerger; Yumirle Turmelle; Peter Putnam; Jane Garbutt
Journal:  Acad Pediatr       Date:  2012-05-26       Impact factor: 3.107

6.  The Burden of Disease and Pathology at a Rapidly Expanding Tertiary Paediatric Surgical Unit in South Africa.

Authors:  A Zanini; N Maistry; G Brisighelli; T Gabler; D Harrison; C Westgarth-Taylor; A Withers; J Loveland; N Patel
Journal:  World J Surg       Date:  2021-05-05       Impact factor: 3.352

7.  Biopsy-driven diagnosis in infants with cholestatic jaundice in Iran.

Authors:  Elham Talachian; Ali Bidari; Mitra Mehrazma; Nahid Nick-khah
Journal:  World J Gastroenterol       Date:  2014-01-28       Impact factor: 5.742

8.  Differential expression of hepatic fibrosis mediators in sick and spontaneously recovered mice with experimental biliary atresia.

Authors:  Evan P Nadler; Xiaolu Li; Emeka Onyedika; M Alba Greco
Journal:  J Surg Res       Date:  2009-11-20       Impact factor: 2.192

9.  Impact of consolidation of cases on post-operative outcomes for index pediatric surgery cases.

Authors:  Liese C C Pruitt; David E Skarda; Douglas C Barnhart; Brian T Bucher
Journal:  J Pediatr Surg       Date:  2020-02-25       Impact factor: 2.545

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.